5 Results

People

  1. Curran
    Curran
  2. Barker
    Barker
  3. Boulad
    Boulad
  4. Castro-Malaspina
    Castro-Malaspina
  5. Giralt
    Giralt
  6. Heller
    Heller
  7. Hsu
    Hsu
  8. Jakubowski
    Jakubowski
  9. Kernan
    Kernan
  10. O'Reilly
    O'Reilly

Groups

  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. GSK Faculty (5)
  4. Hematologic Malignancies Research (5)
  5. Hematologic Malignancies, Division of (5)
  6. MSK Grad Students (5)
  7. Pediatrics, Department of (5)
  8. Stem Cell Transplantation and Cellular Therapy Service (5)
  9. Biostatistics Service (4)
  10. Bone Marrow Transplant (4)
  1. "Hematologic Malignancies Research"
  2. "Kevin Curran"
  3. "MSK Grad Students"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. GSK Faculty (5)
  4. Hematologic Malignancies Research (5)
  5. Hematologic Malignancies, Division of (5)
  6. MSK Grad Students (5)

More Groups

People
  1. Kevin Curran (5)
  2. Ann Jakubowski (4)
  3. Craig Sauter (4)
  4. Doris Ponce (4)
  5. Esperanza Papadopoulos (4)
  6. Farid Boulad (4)

More People

Years
  1. 2020 (2)
  2. 2019 (1)
  3. 2015 (1)
  4. 2013 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (1)
  2. Blood (1)
  3. Bone Marrow Transplantation (1)
  4. Cancer Cell (1)
  5. Journal of Clinical Investigation (1)
Publishers
  1. American Society for Clinical Investigation (1)
  2. American Society of Hematology (1)
  3. Cell Press (1)
  4. Elsevier Inc. (1)
  5. Nature Publishing Group (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • CD40 ligand-modified chimeric antigen receptor T cells enhance antitumor function by eliciting an endogenous antitumor response
    Journal Article

    Kuhn, N. F.; Purdon, T. J.; van Leeuwen, D. G.; Lopez, A. V.; Curran, K. J.; Daniyan, A. F.; Brentjens, R. J.
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Barker, J.; Castro-Malaspina, H.; Curran, K.; Giralt, S.; Hasan, A.; Heller, G.; Hsu, K.; Jakubowski, A.; more...
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
    Blood (2013)

    Fulltext@MSK | Save